Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Propofol TIVA in Thyroidectomy
NCT05047939Completed
- Sponsor
- Seoul National University Hospital
- Start
- Dec 2021
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of remimazolam (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Time from the end of anesthetic administration to eye-opening. Started Dec 2021; status: completed.
02
Drugs
remimazolam
Beyond the preview
Go deeper on NCT05047939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05047939.